+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Cell Reprogramming Market by Technology (Episomal Reprogramming, mRNA Reprogramming, Sendai Virus-Based Reprogramming), Application (Research, Therapeutic), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715495
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cell Reprogramming Market size was estimated at USD 375.59 million in 2023, USD 413.88 million in 2024, and is expected to grow at a CAGR of 10.59% to reach USD 759.92 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Reprogramming Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Reprogramming Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Reprogramming Market, highlighting leading vendors and their innovative profiles. These include ALSTEM Inc., Applied Biological Materials Inc., Axol Bioscience Ltd., Bit Bio Ltd., Bristol Myers Squibb Company, CD Biosynsis, Cell Reprogramming & Therapeutics LLC, Cellular Reprogramming, Inc., Creative Bioarray, DefiniGEN Limited, Fujifilm LImited, Lonza AG, Merck KGaA, Mogrify Limited, REPROCELL Inc., Stemnovate Limited, Takara Bio Inc., Thermo Fisher Scientific, Inc., TOKIWA-Bio inc.,, and ?Allele Biotechnology and Pharmaceuticals, Inc.

Market Segmentation & Coverage

This research report categorizes the Cell Reprogramming Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Episomal Reprogramming
    • mRNA Reprogramming
    • Sendai Virus-Based Reprogramming
  • Application
    • Research
    • Therapeutic
  • End-Use
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Clinics
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cell Reprogramming Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Reprogramming Market?
  3. What are the technology trends and regulatory frameworks in the Cell Reprogramming Market?
  4. What is the market share of the leading vendors in the Cell Reprogramming Market?
  5. Which modes and strategic moves are suitable for entering the Cell Reprogramming Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cell Reprogramming Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Applications in regenerative medicine and disease modeling
5.1.1.2. Adoption of advanced technologies in stem cell research and therapies
5.1.1.3. Rise in drug discovery and drug development activities
5.1.2. Restraints
5.1.2.1. High cost of cell reprogramming
5.1.3. Opportunities
5.1.3.1. Advancements in cellular reprogramming
5.1.3.2. Significant investments in cell reprogramming
5.1.4. Challenges
5.1.4.1. Technical issues and limitations of cell reprogramming
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cell Reprogramming Market, by Technology
6.1. Introduction
6.2. Episomal Reprogramming
6.3. mRNA Reprogramming
6.4. Sendai Virus-Based Reprogramming
7. Cell Reprogramming Market, by Application
7.1. Introduction
7.2. Research
7.3. Therapeutic
8. Cell Reprogramming Market, by End-Use
8.1. Introduction
8.2. Biotechnology & Pharmaceutical Companies
8.3. Hospitals & Clinics
8.4. Research & Academic Institutes
9. Americas Cell Reprogramming Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cell Reprogramming Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cell Reprogramming Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. ALSTEM Inc.
13.1.2. Applied Biological Materials Inc.
13.1.3. Axol Bioscience Ltd.
13.1.4. Bit Bio Ltd.
13.1.5. Bristol Myers Squibb Company
13.1.6. CD Biosynsis
13.1.7. Cell Reprogramming & Therapeutics LLC
13.1.8. Cellular Reprogramming, Inc.
13.1.9. Creative Bioarray
13.1.10. DefiniGEN Limited
13.1.11. Fujifilm LImited
13.1.12. Lonza AG
13.1.13. Merck KGaA
13.1.14. Mogrify Limited
13.1.15. REPROCELL Inc.
13.1.16. Stemnovate Limited
13.1.17. Takara Bio Inc.
13.1.18. Thermo Fisher Scientific, Inc.
13.1.19. TOKIWA-Bio inc.,
13.1.20. ?Allele Biotechnology and Pharmaceuticals, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. CELL REPROGRAMMING MARKET RESEARCH PROCESS
FIGURE 2. CELL REPROGRAMMING MARKET SIZE, 2023 VS 2030
FIGURE 3. CELL REPROGRAMMING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL REPROGRAMMING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELL REPROGRAMMING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL REPROGRAMMING MARKET DYNAMICS
FIGURE 7. CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CELL REPROGRAMMING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CELL REPROGRAMMING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CELL REPROGRAMMING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CELL REPROGRAMMING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CELL REPROGRAMMING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CELL REPROGRAMMING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL REPROGRAMMING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. CELL REPROGRAMMING MARKET SIZE, BY EPISOMAL REPROGRAMMING, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELL REPROGRAMMING MARKET SIZE, BY MRNA REPROGRAMMING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CELL REPROGRAMMING MARKET SIZE, BY SENDAI VIRUS-BASED REPROGRAMMING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. CELL REPROGRAMMING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CELL REPROGRAMMING MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 13. CELL REPROGRAMMING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CELL REPROGRAMMING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CELL REPROGRAMMING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 26. CANADA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. CANADA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. CANADA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. MEXICO CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. MEXICO CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CELL REPROGRAMMING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. CHINA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. CHINA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CHINA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. INDIA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. INDIA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. INDIA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. JAPAN CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. JAPAN CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. THAILAND CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. THAILAND CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CELL REPROGRAMMING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. DENMARK CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. DENMARK CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. EGYPT CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EGYPT CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. FINLAND CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. FINLAND CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. FRANCE CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. FRANCE CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. GERMANY CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. ITALY CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. ITALY CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ITALY CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. NORWAY CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. NORWAY CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. POLAND CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. POLAND CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. POLAND CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. QATAR CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. QATAR CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. QATAR CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. SPAIN CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SPAIN CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. TURKEY CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. TURKEY CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM CELL REPROGRAMMING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM CELL REPROGRAMMING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM CELL REPROGRAMMING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. CELL REPROGRAMMING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 144. CELL REPROGRAMMING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 145. CELL REPROGRAMMING MARKET LICENSE & PRICING

Companies Mentioned

  • ALSTEM Inc.
  • Applied Biological Materials Inc.
  • Axol Bioscience Ltd.
  • Bit Bio Ltd.
  • Bristol Myers Squibb Company
  • CD Biosynsis
  • Cell Reprogramming & Therapeutics LLC
  • Cellular Reprogramming, Inc.
  • Creative Bioarray
  • DefiniGEN Limited
  • Fujifilm LImited
  • Lonza AG
  • Merck KGaA
  • Mogrify Limited
  • REPROCELL Inc.
  • Stemnovate Limited
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • TOKIWA-Bio inc.,
  • ​Allele Biotechnology and Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Table Information